Search

Your search keyword '"Laia Garrigos"' showing total 4 results
Start Over Author "Laia Garrigos" Publisher american society of clinical oncology (asco)
4 results on '"Laia Garrigos"'

1. Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study—GETHI 2013-01

Author

Jf. Rodriguez-Moreno, Jesús García-Donas, Laia Garrigos, Nuria Laínez, Ana Santaballa, Andrés Redondo, Juan Fernando Cueva, Maria Jesus Rubio, Susana Hernando Polo, Isabel Bover, Isabel Palacio, Zaida Garcia-Casado, Enrique Grande, and Alicia Hurtado

Subjects
Cancer Research, Oncology
Published
2015
Full Text
View/download PDF

2. Bone turnover markers at 3 months of aromatase inhibitor therapy for prediction of 1-year bone mineral density loss: The B-ABLE cohort

Author

Xavi Nogues, Ignacio Tusquets, Elisabet Torres, D Prieto-Alhambra, Laia Garrigos, Tamara Martos, Maria Rodriguez-Sanz, Joan Albanell, Sonia Servitja, and Adolf Diez-Perez

Subjects
Bone mineral, Oncology, Cancer Research, medicine.medical_specialty, Aromatase inhibitor, medicine.drug_class, business.industry, Bone remodeling, Endocrinology, Internal medicine, Cohort, medicine, Bisphosphonate therapy, business
Abstract

581 Background: Most guidelines recommend bone mineral density (BMD) monitoring at 1-2 years of aromatase inhibitor (AI) therapy for women who do not need bisphosphonate therapy according to baseli...

Published
2014
Full Text
View/download PDF

3. Concordance between radiologic and pathologic complete response in patients with breast cancer treated with neoadjuvant chemotherapy

Author

Ana Rodríguez-Arana, Maria Martinez-Garcia, Josep M. Corominas, Joan Albanell, Ignacio Tusquets, Maria Dolors Sabadell, Sonia Servitja, Laia Garrigos, Tamara Martos, and Iria Gonzalez

Subjects
Cancer Research, Chemotherapy, medicine.medical_specialty, medicine.diagnostic_test, business.industry, medicine.medical_treatment, Concordance, Pathological response, Magnetic resonance imaging, medicine.disease, Breast cancer, Oncology, Medicine, In patient, Radiology, business, Complete response
Abstract

e12028 Background: Magnetic Resonance Imaging (MRI) is accepted as the best exploration to predict pathological response to neoadjuvant chemotherapy(NAC) in breast cancer. Our goal is to analyze th...

Published
2014
Full Text
View/download PDF

4. Vitamin D repletion and prevention of bone loss in nonosteoporotic women with breast cancer

Author

Joan Albanell, Laia Garrigos, Adolf Diez-Perez, Xavi Nogues, D Prieto-Alhambra, Sonia Servitja, Maria Jesus Peña, Ignasi Tusquets, and Maria Martinez-Garcia

Subjects
Oncology, Fracture risk, Cancer Research, medicine.medical_specialty, Aromatase inhibitor, medicine.drug_class, business.industry, medicine.disease, Breast cancer, Internal medicine, medicine, Vitamin D and neurology, business
Abstract

9026 Background: Aromatase inhibitor (AI)-associated bone loss increases fracture rates. Vitamin D might play a role in minimizing this fracture risk. We sought to assess the association between 25...

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results